Description
Pharvax Biosciences offers VAXSTOP, a combination tablet that contains 500mg of Tranexamic acid and 250mg of Mefenamic acid. It is available in tablet dosage form, and it is included in the company’s gynaecology and women’s healthcare product portfolio. VAXSTOP combines Tranexamic Acid, an antifibrinolytic ingredient, with Mefenamic Acid, an NSAID. This combination gives the product a distinct position within the gynaecological pharmaceutical segment and makes it a relevant option for pharma businesses developing a women’s healthcare product range.
For PCD pharma franchise partners, VAXSTOP can be considered as an addition to a gynaecology-focused product portfolio. It can complement other pharmaceutical formulations and help partners offer a broader range of products for their selected markets.
Product Details:
- Brand Name: VAXSTOP
- Composition: Tranexamic Acid 500 mg + Mefenamic Acid 250 mg
- Dosage Form: Tablets
- Category: Gynaecological / Women’s Healthcare
- Packaging: 10 × 10 Tablets
- Business Segment: PCD Pharma Franchise
- Target Partners: PCD Franchise Partners, Pharma Marketers, Distributors & Stockists
Affordable PCD Pharma Franchise Opportunity for Tranexamic and Mefenamic Acid Tablets – Pharvax Biosciences
As a trusted pharma franchise company in India, Pharvax Biosciences offers a PCD pharma franchise opportunity for Tranexamic and Mefenamic Acid Tablets under its own brand name, VAXSTOP, along with monopoly rights and promotional tools across India. This combination product can be a useful addition for PCD pharma franchise partners, pharma marketers, distributors, and stockists looking to expand their gynaecology and women’s healthcare product portfolio.
With a wide product portfolio, quality-focused manufacturing, and applicable GMP/ISO certifications, Pharvax Biosciences supports partners in marketing and distributing pharmaceutical products in their selected territories. PCD partners can enquire about pricing, minimum order requirements, packaging, monopoly rights, territory availability, and other franchise terms directly with Pharvax Biosciences.
Why Choose VAXSTOP Tablet?
- Specialised Combination: Tranexamic Acid 500 mg + Mefenamic Acid 250 mg.
- Women’s Healthcare: Suitable for a focused gynaecology portfolio.
- Product Variety: Adds another specialised tablet to your range.
- PCD-Friendly: Suitable for pharma marketing and distribution.
- Business Opportunity: Ideal for PCD partners, distributors, and marketers.
- Portfolio Growth: Helps expand your gynaecology product basket.
Who Can Enquire About VAXSTOP?
VAXSTOP tablet may be relevant for:
- PCD Pharma Franchise Partners
- Gynaecology-focused Pharma Marketers
- Pharmaceutical Distributors
- Pharma Stockists
- Pharma Wholesalers
- Pharma Marketing Companies
- Healthcare Product Distributors
- Pharma Entrepreneurs
- Existing PCD companies expanding their women’s healthcare range
Disclaimer: The information provided on this page is for informational and business purposes only. It is not a prescription, medical advice, diagnosis, treatment recommendation, or substitute for advice from a qualified healthcare professional.
